Department of Endodontics, Hospital of Stomatology, Jilin University, Changchun, Jilin, China.
Department of Prosthodontics, Hospital of Stomatology, Jilin University, Changchun, Jilin, China.
Neoplasma. 2021 Nov;68(6):1201-1211. doi: 10.4149/neo_2021_210421N544. Epub 2021 Sep 28.
Exploring the molecular mechanism of oral squamous cell carcinoma (OSCC) pathogenesis is of great significance for its improvement and therapy. Non-structural maintenance of chromatin condensin I complex subunit G (NCAPG) is responsible for chromatin condensation and is associated with the progression of many malignant tumors. This study was aimed to investigate the role of NCAPG on OSCC pathogenesis. NCAPG mRNA expression data in OSCC tissues were obtained from the Gene Expression Omnibus (GEO) database and NCAPG protein expression in OSCC cell lines was determined by western blotting analysis. The results demonstrated that NCAPG expression in OSCC tissues and cells was higher than that of normal control. Following the short interfering RNA (siRNA) knockdown of NCAPG in two OSCC cell lines, we observed that NCAPG depletion notably inhibited OSCC proliferation and cell cycle progression, as well as promoted apoptosis in vitro. Besides, silencing of NCAPG specifically inhibited the GSK-3β/β-catenin signaling. Furthermore, we demonstrated that NCAPG was a downstream target of miR-378a-3p. NCAPG silencing counteracted the effect of the miR-378a-3p inhibitor on cell proliferation/cycle induction. Collectively, these findings suggest that NCAPG is crucial in OSCC progression and development, and may serve as a potential therapeutic target for OSCC.
探索口腔鳞状细胞癌 (OSCC) 发病机制的分子机制对其改善和治疗具有重要意义。非结构性染色质凝聚素 I 复合物亚基 G(NCAPG)负责染色质凝聚,与许多恶性肿瘤的进展有关。本研究旨在探讨 NCAPG 在 OSCC 发病机制中的作用。从基因表达综合数据库 (GEO) 数据库中获取 OSCC 组织中的 NCAPG mRNA 表达数据,并通过 Western blot 分析确定 OSCC 细胞系中的 NCAPG 蛋白表达。结果表明,NCAPG 在 OSCC 组织和细胞中的表达高于正常对照。在两种 OSCC 细胞系中用短发夹 RNA (siRNA) 敲低 NCAPG 后,我们观察到 NCAPG 耗竭显著抑制了 OSCC 的体外增殖和细胞周期进程,并促进了细胞凋亡。此外,沉默 NCAPG 特异性抑制了 GSK-3β/β-catenin 信号通路。此外,我们证明 NCAPG 是 miR-378a-3p 的下游靶标。NCAPG 沉默逆转了 miR-378a-3p 抑制剂对细胞增殖/周期诱导的作用。总之,这些发现表明 NCAPG 在 OSCC 的进展和发展中至关重要,可能成为 OSCC 的潜在治疗靶点。